In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In High-risk Patients With Chronic Obstructive Pulmonary Disease, Dupilumab Slightly Reduces Moderate Exacerbation (BOREAS)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315924/all/In_high_risk_patients_with_chronic_obstructive_pulmonary_disease__dupilumab_slightly_reduces_moderate_exacerbation__BOREAS_.
In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315924/all/In_high_risk_patients_with_chronic_obstructive_pulmonary_disease__dupilumab_slightly_reduces_moderate_exacerbation__BOREAS_. Accessed December 7, 2024.
In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315924/all/In_high_risk_patients_with_chronic_obstructive_pulmonary_disease__dupilumab_slightly_reduces_moderate_exacerbation__BOREAS_
In High-risk Patients With Chronic Obstructive Pulmonary Disease, Dupilumab Slightly Reduces Moderate Exacerbation (BOREAS) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315924/all/In_high_risk_patients_with_chronic_obstructive_pulmonary_disease__dupilumab_slightly_reduces_moderate_exacerbation__BOREAS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
ID - 1315924
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315924/all/In_high_risk_patients_with_chronic_obstructive_pulmonary_disease__dupilumab_slightly_reduces_moderate_exacerbation__BOREAS_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -